The efficacy of cognitive-behavior group therapy on health-related quality of life, health anxiety and depression in patients with diarrhea-predominant irritable bowel syndrome

Pakistan Journal of Medical Sciences

Volumn 27, Issue 4, 2011, Pages 749-753

  Haghayegh, Sayed Abbas ^b   Kalantari, Mehrdad ^b   Molavi, Hosein ^b   Talebi, Majid ^a   Alemohamad, Javad ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF ISFAHAN   (Iran)

Author keywords

Cognitive behavior group therapy; Depression; Health anxiety; Irritable bowel syndrome; Quality of life

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; IRRITABLE COLON; MALE; QUALITY OF LIFE; THERAPY EFFECT;

EID: 80053034617     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Drossman DA. The functional gastrointestinal disorders and the Rome III process. J Gastroenterology 2006;130(5):1377-1390.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders: J Gastroenterology 2006;130(5):1480-1491.
3. Lee OY, Mayer EA, Schmulson M, Chang L, Naliboff B. Gender-related differences in IBS symptoms. Am J Gastroenterol 2001;96(7):2184-2193.
4. Khanna D, Tsevat J. Health-related quality of life-an introduction. Am J Manag Care 2007;13(Suppl 9):S218-223.
5. Costanza R, Fisher B, Ali S, Beer C, Bond L, Boumans R, et al. Quality of life: An approach integrating opportunities, Human needs, and subjective well-being. J Ecological Economics 2007;61:267-276.
6. Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, et al. Further validation of the IBS -QOL: A disease-specific Quality of life Questionnaire. J Gastroenterology 2000;95:999-1007.
7. Bize R, Johnson JA, Plotinkoff RC. Physical activity level and health-related quality of life in the general adult population: A systematic review. J Prev Med 2007;45:401-415.
8. Frank L, Kleinman L, Rentz A, Cielsa G, Kim J, Zacker C. Health-related quality of life associated with irritable bowel syndrome, comparison with other chronic disease. J Clin Ther 2002;24:675-689.
9. Mc Alinden NM, Oei TPS. Validation of the quality of life inventory for patients with anxiety and depression. J Comprehensive Psychiatry 2006;43:307-314.
10. Groll D, Vanner SJ, Dpew WT, Dacosta LR, Simon JB, Groll A, et al. The IBS 36: A New quality of life measure for irritable bowel syndrome. Am J Gastro 2002;97:962-997.
11. Gralnek IM, Hays RD, Kilbourne AM, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. J Gastroenterology. 2000;119:654-660.
12. Lea R, Whorwell P. Quality of life in irritable bowel syndrome. J Pharmacy Economics 2001;19:643-653.
13. Masand PS, Pae C, Krulewicz S, Peindl KA. Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome. J Psychosomatics 2009;50(1):78-79.
14. Thompson WB. Functional bowel disorders and functional abdominal pain. Dungeon Associates Incorporated 2000: 351-432.
15. Lackner JM. No brain, No gain: The role of cognitive processes in irritable bowel syndrome. J Cognitive Psychotherapy 2005;19(2):125-136.
16. Whitehed WE, Palsson OS, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with disorders: What are the causes and implications? J Gastroenterology 2002;122:1140-1156.
17. Kumano H, Kaiya H, Yoshiucki K, Yamanaka G, Sasaki T, Kuboki T. Comorbidity of irritable bowel syndrome, Panic disorder, and agoraphobia in Japanese representative sample. Am J Gastroenterology 2004;99(2):370-379.
18. Taylor S, Asmundson GJG. Treating health anxiety: A cognitive - behavioral approach. New York: Guilford, 2004.
19. Vandvick PO, Wilhelmsen I, Farup PG: Health anxiety predicts persisting complaints in IBS patients. J Gastroenterology 2003;124:529-530.
20. Abramowitz JS, Braddock AE. Psychological treatment of health anxiety & hypochondriasis: A biopsychosocial approach. Cambridge, MA: Hogrefe & Huber Publishing, 2008.
21. Marcus DK, Gurley JR, Marchi MM, Bauer C. Cognitive and percepyual variables in hypochondriasis and health anxiety: A systematic review. J Clinical Psychology Review 2007;27:127-139.
22. Olatunji BO, Tolin DF, Lohr JM. Irritable bowel syndrome: Associated features and the efficacy of psychosocial treatments. J Applied and Preventive Psychology 2004;11:125-140.
23. Blanchard EB. Irritable Bowel Syndrome: Psychological assessment and treatment. Washington: APA, 2001: 210-246.
24. Patrick DL, Drossman DA, Fredrick IO, Dicesare J, Puder KL. Quality of life in persons with irritable bowel syndrome development and validation of a new measure. J Digestive Disease and Sciences 1998;43(2):400-411.
25. Park JM, Choi MG, Oh JH, Cho YK, Lee IS, Him SW, et al. Crosscultural validation of irritable bowel syndrome quality of life in korea. J Digestive Disease and Sciences 2006;51:1478-1484.
26. Blanchard EB, Lackner JM, Gusmano R, Gudleski GD, Ianders K, Keefe L, et al. Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy: J Behavior Research and Therapy 2006;44:317-337.
27. Lackner JM, Gellman R, Cudleski G, Sanders K, Krasner S, Katz L, et al. Dysfunctional attitudes, gender, and psychopathology as predicts of pain affect in patients with irritable bowel syndrome. J Cognitive Psychotherapy 2005;19(2):151-161.